Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Covid-19 Impact on Bacterial & Viral Specimen Collection Market Is Expected At A CAGR Of 14.0% 2027

According to a recent report published by Grand View Research Inc., increasing cases of influenza and demand for swabs due to the ongoing COVID-19 pandemic, are accelerating the market expansion.

According to a report, “Bacterial & Viral Specimen Collection Market Size, Share & Trends Analysis Report By Product (Swabs, Blood Collection Kits, VTM), By Application (Diagnostics, Research), By End Use, By Region, And Segment Forecasts, 2020–2027”, published by Grand View Research, Inc. The global bacterial & viral specimen collection market size is projected to reach USD 38.8 billion by 2027, registering a CAGR of 14.0%, as per a new report by Grand View Research Inc. The advent of high-end methods, including multiplex PCR, next-generation sequencing, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry have allowed robust diseases diagnosis and rapid microbial identification.

A rise in the prevalence of infectious ailments has impelled industry players offer affordable and easy-to-use tests. As per the 2020 report by the Centers for Disease Control and Prevention (CDC), there were approximately 8,920 new Tuberculosis (TB) cases in the U.S. Such instances have driven the development of medical technology. In July 2020, the Foundation for Innovative New Diagnostics and Cepheid, Inc. launched Xpert MTB/XDR, a rapid molecular test for drug-resistance TB profiling. Similar trends are spurring the market growth.

Operating end-users including clinical laboratories are following standardized protocols to streamline the usage of market products. This is because inaccurate results during specimen collection can affect patient care, laboratory efficiency, hospital infection control, and associated costs. The Texas Department of State Health Services is such regulatory agency that is engaged in rolling out guidelines for suitable collecting and processing methods, thus positively influencing the market growth.

Inquire before purchase:
www.grandviewresearch.com/industry-analysis/bacterial-viral-specimen-collection-market/request/rs1

Bacterial & Viral Specimen Collection Market Highlights

  1. According to the American Chemical Societyultra-absorptive nanofiber swabs can provide rapid and sensitive diagnosis of SARS-CoV-2 virus. The porous nanofiber cylinders promises to minimize the number of false-negative tests. Presently, the most optimal test for COVID-19 strain involves using a long swab for specimen collection from deep inside a patient’s nose. Later the specimen is tested using reverse transcriptase-polymerase chain reaction (RT-PCR) method to detect SARS-CoV-2 RNA
  2. In January 2021, GenTegra announced the validation of their two novel sample collection tube devices called as the direct-into-PCR GenTegra GTR-STMdk and GenTegra GTR-STM. The Active Chemical Protection (ACP) technology has been incorporated in these devices to eliminates the need for time consuming and expensive RNA extraction in Covid-19 detection tests
  3. In January 2021, Helix Specialty Diagnostics entered in a collaboration with Genomic LTC DX to develop the Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Covid-19 testing kits on the Biomark HD platform. This development aims to facilitate 3,000 tests per day
  4. In January 2021, EKF Diagnostics has increased the production of their new PrimeStore MTM, in addition to their previous portfolio: the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit under the COVID-19 testing regime
  5. Asia Pacific market is projected to register a lucrative growth rate in the coming years due to several initiatives undertaken by the emerging economies. For instance, China emerged as the primary exporter of Coivid-19 testing kits to Europe and other parts of the world

Inquire before purchase:
www.grandviewresearch.com/industry-analysis/bacterial-viral-specimen-collection-market/request/rs1

Bacterial & Viral Specimen Collection Market Segmentations

Grand View Research has segmented the global bacterial and viral specimen collection market on the basis of product, application, end-use, and region:

Bacterial & Viral Specimen Collection Product Outlook (Revenue, USD Million, 2016–2027)

  • Bacterial Specimen Collection
  • Swabs
  • Bacterial Transport Media
  • Blood Collection Kits
  • Other Consumables
  • Viral Specimen Collection
  • Swabs
  • Viral Transport Media
  • Blood Collection Kits
  • Other Consumables

Bacterial & Viral Specimen Collection Application Outlook (Revenue, USD Million, 2016–2027)

  • Diagnostics
  • Research

Bacterial & Viral Specimen Collection End-use Outlook (Revenue, USD Million, 2016–2027)

  • Hospitals & Clinics
  • Home Test
  • Research Laboratories

Bacterial & Viral Specimen Collection Regional Outlook (Revenue, USD Million, 2016–2027)

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • The U.K.
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa (MEA)
  • South Africa
  • UAE

List of Key Players of Bacterial & Viral Specimen Collection Market

  • Puritan Medical Products
  • COPAN Diagnostics
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Quidel Corporation
  • Longhorn Vaccines and Diagnostics, LLC
  • Pretium Packaging
  • Trinity Biotech
  • Medical Wire & Equipment
  • HiMedia Laboratories
  • Hardy Diagnostics
  • Nest Scientific
  • VIRCELL S.L.
  • DiaSorin
  • Titan Biotech


This post first appeared on Market Research Reports, please read the originial post: here

Share the post

Covid-19 Impact on Bacterial & Viral Specimen Collection Market Is Expected At A CAGR Of 14.0% 2027

×

Subscribe to Market Research Reports

Get updates delivered right to your inbox!

Thank you for your subscription

×